Global Radiopharmaceuticals for Therapeutic Market Research Report 2023
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
According to QYResearch’s new survey, global Radiopharmaceuticals for Therapeutic market is projected to reach US$ 4734 million in 2029, increasing from US$ 1771 million in 2022, with the CAGR of 15.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Radiopharmaceuticals for Therapeutic market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiopharmaceuticals for Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Radiopharmaceuticals for Therapeutic market is projected to reach US$ 4734 million in 2029, increasing from US$ 1771 million in 2022, with the CAGR of 15.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Radiopharmaceuticals for Therapeutic market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiopharmaceuticals for Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant Radiopharma
- Lantheus
- Aurobindo Pharma
- International Isotopes
- Mundipharma
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals for Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Radiopharmaceuticals for Therapeutic Market Perspective (2018-2029)
2.2 Radiopharmaceuticals for Therapeutic Growth Trends by Region
2.2.1 Global Radiopharmaceuticals for Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiopharmaceuticals for Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceuticals for Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Radiopharmaceuticals for Therapeutic Market Dynamics
2.3.1 Radiopharmaceuticals for Therapeutic Industry Trends
2.3.2 Radiopharmaceuticals for Therapeutic Market Drivers
2.3.3 Radiopharmaceuticals for Therapeutic Market Challenges
2.3.4 Radiopharmaceuticals for Therapeutic Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Radiopharmaceuticals for Therapeutic Players by Revenue
3.1.1 Global Top Radiopharmaceuticals for Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceuticals for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceuticals for Therapeutic Revenue
3.4 Global Radiopharmaceuticals for Therapeutic Market Concentration Ratio
3.4.1 Global Radiopharmaceuticals for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceuticals for Therapeutic Revenue in 2022
3.5 Radiopharmaceuticals for Therapeutic Key Players Head office and Area Served
3.6 Key Players Radiopharmaceuticals for Therapeutic Product Solution and Service
3.7 Date of Enter into Radiopharmaceuticals for Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RADIOPHARMACEUTICALS FOR THERAPEUTIC BREAKDOWN DATA BY TYPE
4.1 Global Radiopharmaceuticals for Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Type (2024-2029)
5 RADIOPHARMACEUTICALS FOR THERAPEUTIC BREAKDOWN DATA BY APPLICATION
5.1 Global Radiopharmaceuticals for Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
6.2 North America Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
6.4 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
7.2 Europe Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
9.2 Latin America Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Radiopharmaceuticals for Therapeutic Introduction
11.1.4 Bayer Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Radiopharmaceuticals for Therapeutic Introduction
11.2.4 Novartis Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Detail
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Introduction
11.3.4 China Isotope & Radiation Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Detail
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Introduction
11.4.4 Dongcheng Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Detail
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Introduction
11.5.4 Q BioMed Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Detail
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Introduction
11.6.4 Curium Pharmaceuticals Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Detail
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Introduction
11.7.4 Jubilant Radiopharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.7.5 Jubilant Radiopharma Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Detail
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Radiopharmaceuticals for Therapeutic Introduction
11.8.4 Lantheus Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.8.5 Lantheus Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Detail
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Introduction
11.9.4 Aurobindo Pharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.9.5 Aurobindo Pharma Recent Development
11.10 International Isotopes
11.10.1 International Isotopes Company Detail
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Radiopharmaceuticals for Therapeutic Introduction
11.10.4 International Isotopes Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.10.5 International Isotopes Recent Development
11.11 Mundipharma
11.11.1 Mundipharma Company Detail
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Radiopharmaceuticals for Therapeutic Introduction
11.11.4 Mundipharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.11.5 Mundipharma Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals for Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Radiopharmaceuticals for Therapeutic Market Perspective (2018-2029)
2.2 Radiopharmaceuticals for Therapeutic Growth Trends by Region
2.2.1 Global Radiopharmaceuticals for Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiopharmaceuticals for Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Radiopharmaceuticals for Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Radiopharmaceuticals for Therapeutic Market Dynamics
2.3.1 Radiopharmaceuticals for Therapeutic Industry Trends
2.3.2 Radiopharmaceuticals for Therapeutic Market Drivers
2.3.3 Radiopharmaceuticals for Therapeutic Market Challenges
2.3.4 Radiopharmaceuticals for Therapeutic Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Radiopharmaceuticals for Therapeutic Players by Revenue
3.1.1 Global Top Radiopharmaceuticals for Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Radiopharmaceuticals for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceuticals for Therapeutic Revenue
3.4 Global Radiopharmaceuticals for Therapeutic Market Concentration Ratio
3.4.1 Global Radiopharmaceuticals for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceuticals for Therapeutic Revenue in 2022
3.5 Radiopharmaceuticals for Therapeutic Key Players Head office and Area Served
3.6 Key Players Radiopharmaceuticals for Therapeutic Product Solution and Service
3.7 Date of Enter into Radiopharmaceuticals for Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RADIOPHARMACEUTICALS FOR THERAPEUTIC BREAKDOWN DATA BY TYPE
4.1 Global Radiopharmaceuticals for Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Type (2024-2029)
5 RADIOPHARMACEUTICALS FOR THERAPEUTIC BREAKDOWN DATA BY APPLICATION
5.1 Global Radiopharmaceuticals for Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
6.2 North America Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
6.4 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
7.2 Europe Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
7.4 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
9.2 Latin America Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Radiopharmaceuticals for Therapeutic Introduction
11.1.4 Bayer Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Radiopharmaceuticals for Therapeutic Introduction
11.2.4 Novartis Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Detail
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Introduction
11.3.4 China Isotope & Radiation Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.3.5 China Isotope & Radiation Recent Development
11.4 Dongcheng
11.4.1 Dongcheng Company Detail
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Introduction
11.4.4 Dongcheng Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.4.5 Dongcheng Recent Development
11.5 Q BioMed
11.5.1 Q BioMed Company Detail
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Introduction
11.5.4 Q BioMed Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.5.5 Q BioMed Recent Development
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Detail
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Introduction
11.6.4 Curium Pharmaceuticals Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.6.5 Curium Pharmaceuticals Recent Development
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Detail
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Introduction
11.7.4 Jubilant Radiopharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.7.5 Jubilant Radiopharma Recent Development
11.8 Lantheus
11.8.1 Lantheus Company Detail
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Radiopharmaceuticals for Therapeutic Introduction
11.8.4 Lantheus Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.8.5 Lantheus Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Detail
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Introduction
11.9.4 Aurobindo Pharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.9.5 Aurobindo Pharma Recent Development
11.10 International Isotopes
11.10.1 International Isotopes Company Detail
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Radiopharmaceuticals for Therapeutic Introduction
11.10.4 International Isotopes Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.10.5 International Isotopes Recent Development
11.11 Mundipharma
11.11.1 Mundipharma Company Detail
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Radiopharmaceuticals for Therapeutic Introduction
11.11.4 Mundipharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023)
11.11.5 Mundipharma Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Radiopharmaceuticals for Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Radiopharmaceuticals for Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Radiopharmaceuticals for Therapeutic Market Share by Region (2018-2023)
Table 10. Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Radiopharmaceuticals for Therapeutic Market Share by Region (2024-2029)
Table 12. Radiopharmaceuticals for Therapeutic Market Trends
Table 13. Radiopharmaceuticals for Therapeutic Market Drivers
Table 14. Radiopharmaceuticals for Therapeutic Market Challenges
Table 15. Radiopharmaceuticals for Therapeutic Market Restraints
Table 16. Global Radiopharmaceuticals for Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Radiopharmaceuticals for Therapeutic Market Share by Players (2018-2023)
Table 18. Global Top Radiopharmaceuticals for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Therapeutic as of 2022)
Table 19. Ranking of Global Top Radiopharmaceuticals for Therapeutic Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Radiopharmaceuticals for Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Radiopharmaceuticals for Therapeutic Product Solution and Service
Table 23. Date of Enter into Radiopharmaceuticals for Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2018-2023)
Table 27. Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2024-2029)
Table 29. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2018-2023)
Table 31. Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2024-2029)
Table 33. North America Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 48. Bayer Company Detail
Table 49. Bayer Business Overview
Table 50. Bayer Radiopharmaceuticals for Therapeutic Product
Table 51. Bayer Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 52. Bayer Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Radiopharmaceuticals for Therapeutic Product
Table 56. Novartis Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. China Isotope & Radiation Company Detail
Table 59. China Isotope & Radiation Business Overview
Table 60. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product
Table 61. China Isotope & Radiation Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 62. China Isotope & Radiation Recent Development
Table 63. Dongcheng Company Detail
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Radiopharmaceuticals for Therapeutic Product
Table 66. Dongcheng Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 67. Dongcheng Recent Development
Table 68. Q BioMed Company Detail
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Radiopharmaceuticals for Therapeutic Product
Table 71. Q BioMed Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 72. Q BioMed Recent Development
Table 73. Curium Pharmaceuticals Company Detail
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product
Table 76. Curium Pharmaceuticals Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 77. Curium Pharmaceuticals Recent Development
Table 78. Jubilant Radiopharma Company Detail
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product
Table 81. Jubilant Radiopharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 82. Jubilant Radiopharma Recent Development
Table 83. Lantheus Company Detail
Table 84. Lantheus Business Overview
Table 85. Lantheus Radiopharmaceuticals for Therapeutic Product
Table 86. Lantheus Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 87. Lantheus Recent Development
Table 88. Aurobindo Pharma Company Detail
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product
Table 91. Aurobindo Pharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 92. Aurobindo Pharma Recent Development
Table 93. International Isotopes Company Detail
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Radiopharmaceuticals for Therapeutic Product
Table 96. International Isotopes Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 97. International Isotopes Recent Development
Table 98. Mundipharma Company Detail
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Radiopharmaceuticals for Therapeutic Product
Table 101. Mundipharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 1. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Radiopharmaceuticals for Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Radiopharmaceuticals for Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Radiopharmaceuticals for Therapeutic Market Share by Region (2018-2023)
Table 10. Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Radiopharmaceuticals for Therapeutic Market Share by Region (2024-2029)
Table 12. Radiopharmaceuticals for Therapeutic Market Trends
Table 13. Radiopharmaceuticals for Therapeutic Market Drivers
Table 14. Radiopharmaceuticals for Therapeutic Market Challenges
Table 15. Radiopharmaceuticals for Therapeutic Market Restraints
Table 16. Global Radiopharmaceuticals for Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Radiopharmaceuticals for Therapeutic Market Share by Players (2018-2023)
Table 18. Global Top Radiopharmaceuticals for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Therapeutic as of 2022)
Table 19. Ranking of Global Top Radiopharmaceuticals for Therapeutic Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Radiopharmaceuticals for Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Radiopharmaceuticals for Therapeutic Product Solution and Service
Table 23. Date of Enter into Radiopharmaceuticals for Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2018-2023)
Table 27. Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Type (2024-2029)
Table 29. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2018-2023)
Table 31. Global Radiopharmaceuticals for Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Application (2024-2029)
Table 33. North America Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 48. Bayer Company Detail
Table 49. Bayer Business Overview
Table 50. Bayer Radiopharmaceuticals for Therapeutic Product
Table 51. Bayer Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 52. Bayer Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Radiopharmaceuticals for Therapeutic Product
Table 56. Novartis Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. China Isotope & Radiation Company Detail
Table 59. China Isotope & Radiation Business Overview
Table 60. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product
Table 61. China Isotope & Radiation Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 62. China Isotope & Radiation Recent Development
Table 63. Dongcheng Company Detail
Table 64. Dongcheng Business Overview
Table 65. Dongcheng Radiopharmaceuticals for Therapeutic Product
Table 66. Dongcheng Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 67. Dongcheng Recent Development
Table 68. Q BioMed Company Detail
Table 69. Q BioMed Business Overview
Table 70. Q BioMed Radiopharmaceuticals for Therapeutic Product
Table 71. Q BioMed Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 72. Q BioMed Recent Development
Table 73. Curium Pharmaceuticals Company Detail
Table 74. Curium Pharmaceuticals Business Overview
Table 75. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product
Table 76. Curium Pharmaceuticals Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 77. Curium Pharmaceuticals Recent Development
Table 78. Jubilant Radiopharma Company Detail
Table 79. Jubilant Radiopharma Business Overview
Table 80. Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product
Table 81. Jubilant Radiopharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 82. Jubilant Radiopharma Recent Development
Table 83. Lantheus Company Detail
Table 84. Lantheus Business Overview
Table 85. Lantheus Radiopharmaceuticals for Therapeutic Product
Table 86. Lantheus Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 87. Lantheus Recent Development
Table 88. Aurobindo Pharma Company Detail
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product
Table 91. Aurobindo Pharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 92. Aurobindo Pharma Recent Development
Table 93. International Isotopes Company Detail
Table 94. International Isotopes Business Overview
Table 95. International Isotopes Radiopharmaceuticals for Therapeutic Product
Table 96. International Isotopes Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 97. International Isotopes Recent Development
Table 98. Mundipharma Company Detail
Table 99. Mundipharma Business Overview
Table 100. Mundipharma Radiopharmaceuticals for Therapeutic Product
Table 101. Mundipharma Revenue in Radiopharmaceuticals for Therapeutic Business (2018-2023) & (US$ Million)
Table 102. Mundipharma Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Radiopharmaceuticals for Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Radiopharmaceuticals for Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Radiopharmaceuticals for Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Radiopharmaceuticals for Therapeutic Market Share by Application: 2022 VS 2029
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Radiopharmaceuticals for Therapeutic Report Years Considered
Figure 14. Global Radiopharmaceuticals for Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Radiopharmaceuticals for Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Radiopharmaceuticals for Therapeutic Market Share by Region: 2022 VS 2029
Figure 17. Global Radiopharmaceuticals for Therapeutic Market Share by Players in 2022
Figure 18. Global Top Radiopharmaceuticals for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Therapeutic as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Radiopharmaceuticals for Therapeutic Revenue in 2022
Figure 20. North America Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 22. United States Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 26. Germany Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Share by Region (2018-2029)
Figure 34. China Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 42. Mexico Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 46. Turkey Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 50. China Isotope & Radiation Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 51. Dongcheng Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 52. Q BioMed Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 53. Curium Pharmaceuticals Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 54. Jubilant Radiopharma Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 55. Lantheus Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 56. Aurobindo Pharma Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 57. International Isotopes Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 58. Mundipharma Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Figure 1. Global Radiopharmaceuticals for Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Radiopharmaceuticals for Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Radiopharmaceuticals for Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Radiopharmaceuticals for Therapeutic Market Share by Application: 2022 VS 2029
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Radiopharmaceuticals for Therapeutic Report Years Considered
Figure 14. Global Radiopharmaceuticals for Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Radiopharmaceuticals for Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Radiopharmaceuticals for Therapeutic Market Share by Region: 2022 VS 2029
Figure 17. Global Radiopharmaceuticals for Therapeutic Market Share by Players in 2022
Figure 18. Global Top Radiopharmaceuticals for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals for Therapeutic as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Radiopharmaceuticals for Therapeutic Revenue in 2022
Figure 20. North America Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 22. United States Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 26. Germany Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Radiopharmaceuticals for Therapeutic Market Share by Region (2018-2029)
Figure 34. China Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 42. Mexico Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Share by Country (2018-2029)
Figure 46. Turkey Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Radiopharmaceuticals for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 50. China Isotope & Radiation Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 51. Dongcheng Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 52. Q BioMed Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 53. Curium Pharmaceuticals Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 54. Jubilant Radiopharma Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 55. Lantheus Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 56. Aurobindo Pharma Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 57. International Isotopes Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 58. Mundipharma Revenue Growth Rate in Radiopharmaceuticals for Therapeutic Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
